Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Tissue Engineering - Part B: Reviews is Scopus-indexed (Q1, CiteScore 13.5), WoS SCIE. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 1937-3368Verify ISSN ↗1937-3376Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biochemistry | 37 / 448 | 91st | Q1 |
| Biomedical Engineering | 34 / 342 | 90th | Q1 |
| Bioengineering | 22 / 168 | 87th | Q1 |
| Biomaterials | 21 / 146 | 85th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q1, CiteScore 13.5.
Tissue Engineering - Part B: Reviews is Q1 in Biochemistry (rank 37 of 448), Q1 in Biomedical Engineering (rank 34 of 342) and Q1 in Bioengineering (rank 22 of 168), by CiteScore 2025. It is ranked in 4 subject areas in all.
Tissue Engineering - Part B: Reviews is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 13.5, which places it in quartile Q1 at the 91st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.157, quartile Q1, with an H-index of 125.
Tissue Engineering - Part B: Reviews is published by SAGE Publications Ltd. Its print ISSN is 1937-3368 and its online ISSN is 1937-3376.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Tissue Engineering - Part B: Reviews has an h-index of 136 and a 2-year mean of 3.62 citations per paper (OpenAlex). Its Scopus CiteScore is 13.5, quartile Q1. On 2-year citations it ranks #145 of 442 Scopus journals in Biochemistry.
Tissue Engineering - Part B: Reviews published 60 papers in 2025; its busiest recent year was 2020 with 84. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from China (54.5%), United States (9.3%) and Iran (6.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.